Oliver Rosen

Oliver Rosen is an accomplished medical professional with extensive experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as Chief Medical Officer at Akamis Bio and a member of the Advisory Board at Kernal Biologics, Oliver also holds notable positions with Community Servings and has previously acted as President and Chief Medical Officer at DynamiCure Biotechnology. Oliver's track record includes significant advancements in drug development, including the successful filing of INDs and the rapid progression of therapies from pre-IND to NDA-readiness at multiple organizations, such as Deciphera Pharmaceuticals and SQZ Biotechnologies. An expert in medical affairs, Oliver has played pivotal roles at Millennium Pharmaceuticals and Genentech, demonstrating a strong foundation in both clinical research and translational medicine. Oliver's educational background includes a medical degree from the University of Cologne and advanced studies in electrophysiological pharmacology from multiple institutions in Germany.